Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 10 | 2025 | 235 | 2.980 |
Why?
|
| Hypothalamic Diseases | 4 | 2022 | 38 | 1.670 |
Why?
|
| Hamartoma | 4 | 2022 | 52 | 1.660 |
Why?
|
| Epilepsy | 5 | 2024 | 891 | 1.140 |
Why?
|
| Vagus Nerve Stimulation | 3 | 2024 | 58 | 1.080 |
Why?
|
| Laser Therapy | 6 | 2025 | 232 | 0.930 |
Why?
|
| Tuberous Sclerosis | 2 | 2023 | 124 | 0.910 |
Why?
|
| Deep Brain Stimulation | 3 | 2024 | 432 | 0.770 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 175 | 0.590 |
Why?
|
| Seizures | 6 | 2025 | 895 | 0.430 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2025 | 3844 | 0.340 |
Why?
|
| Treatment Outcome | 10 | 2025 | 13028 | 0.310 |
Why?
|
| Child, Preschool | 10 | 2025 | 14735 | 0.250 |
Why?
|
| Child | 11 | 2025 | 25783 | 0.240 |
Why?
|
| Young Adult | 7 | 2024 | 9965 | 0.240 |
Why?
|
| Stereotaxic Techniques | 2 | 2025 | 79 | 0.220 |
Why?
|
| Thalamic Nuclei | 1 | 2024 | 18 | 0.220 |
Why?
|
| Drug Hypersensitivity | 1 | 2024 | 100 | 0.200 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17391 | 0.200 |
Why?
|
| Vocal Cord Paralysis | 1 | 2024 | 70 | 0.200 |
Why?
|
| Electric Stimulation Therapy | 1 | 2024 | 84 | 0.200 |
Why?
|
| Electroencephalography | 2 | 2025 | 908 | 0.200 |
Why?
|
| Hemispherectomy | 1 | 2023 | 26 | 0.200 |
Why?
|
| Adolescent | 8 | 2025 | 20557 | 0.200 |
Why?
|
| Laryngoscopy | 1 | 2024 | 161 | 0.190 |
Why?
|
| Verbal Learning | 1 | 2022 | 71 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2024 | 390 | 0.180 |
Why?
|
| Myocarditis | 1 | 2023 | 132 | 0.180 |
Why?
|
| Philadelphia Chromosome | 1 | 2021 | 43 | 0.180 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2021 | 21 | 0.180 |
Why?
|
| Humans | 19 | 2025 | 132199 | 0.180 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 102 | 0.170 |
Why?
|
| Tumor Burden | 1 | 2020 | 248 | 0.150 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 357 | 0.150 |
Why?
|
| Memory | 1 | 2022 | 356 | 0.150 |
Why?
|
| Male | 12 | 2025 | 64979 | 0.140 |
Why?
|
| Female | 12 | 2025 | 70754 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2025 | 5173 | 0.130 |
Why?
|
| Infant | 5 | 2024 | 13048 | 0.120 |
Why?
|
| Bell Palsy | 1 | 2014 | 6 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 2014 | 30 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 2161 | 0.110 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 34 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1679 | 0.100 |
Why?
|
| Adult | 5 | 2024 | 31600 | 0.090 |
Why?
|
| Magnetoencephalography | 1 | 2025 | 46 | 0.060 |
Why?
|
| Kentucky | 1 | 2024 | 28 | 0.060 |
Why?
|
| Electrodes, Implanted | 1 | 2025 | 177 | 0.060 |
Why?
|
| Dysphonia | 1 | 2024 | 18 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2024 | 66 | 0.050 |
Why?
|
| Neck | 1 | 2024 | 142 | 0.050 |
Why?
|
| Electrocorticography | 1 | 2023 | 74 | 0.050 |
Why?
|
| Canada | 1 | 2023 | 337 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 297 | 0.050 |
Why?
|
| Drug Substitution | 1 | 2021 | 20 | 0.040 |
Why?
|
| Imatinib Mesylate | 1 | 2021 | 48 | 0.040 |
Why?
|
| Karyotyping | 1 | 2021 | 317 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 326 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 772 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2020 | 95 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1163 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2313 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 29007 | 0.040 |
Why?
|
| Electrocoagulation | 1 | 2018 | 32 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2021 | 418 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 990 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 602 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2024 | 802 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 608 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 3377 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2230 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 377 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3414 | 0.030 |
Why?
|
| Hydroxycorticosteroids | 1 | 2014 | 1 | 0.030 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2025 | 3139 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1829 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5410 | 0.020 |
Why?
|
| Disease Management | 1 | 2014 | 565 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 3183 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1250 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21456 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 5015 | 0.010 |
Why?
|